The Division of Urology has a rich research background from the early inception of the division with a focus on everything from immunology in renal transplantation to improving patient outcomes and risk stratifying patients with urological conditions.

While taking care of the urological conditions of mid-Missourians, the faculty at the University of Missouri have also been able to contribute to the larger field of urology, surgery and medicine through research endeavors.

Collaborations within the University of Missouri system is highly encouraged and the Division of Urology has embraced this opportunity across the School of Medicine as well as the entire University System. Faculty are directly collaborating with individuals from the following: 

With research goals, also comes education of residents and students. The faculty are proud to mentor and guide these individuals through their own projects from design to final publication. Several Quality Improvement Projects have also been led by the Urology Division including both faculty and staff. These initiatives have been forefront in improving the lives and experiences of patients and employees at MU Health Care.

Faculty have completed and currently have ongoing grants and funding opportunities that have allowed this work to persist. These have been through internal and external mechanisms including PCORI grants, societal grants, institutional grants, and pharmaceutical grants.

Faculty have ongoing Clinical Trials that are Investigator-Initiated as well as through Ellis Fischel Cancer Center Clinical Trials Office. The Division of Urology has been very successful in trial recruitment to improve the current and future care of patients.

2020 Publications

Already in 2020, the Division of Urology has been successful with many peer-reviewed publications:

Ungerer G, Anwar T, Golzy M, and Murray KS. “Living with Bladder Cancer: Self-Reported Changes in Patients’ Functional and Overall Health Status Following Diagnosis.” Eur Urol OS. 2020; 20: 14-19. doi: 10.1016/j.euros.2020.06.007.

Rosen GH, Golzy M, and Murray KS. “Letter to the Editor Re: Delayed Radical Prostatectomy is Not Associated with Adverse Oncological Outcomes: Implication for Men Experiencing Surgical Delay Due to COVID-19 Pandemic.”  J Urol. 2020. Doi: 10.1097/JU.0000000000001089. [Epub ahead of print].

Rosen GH, Golzy M, and Murray KS. “Interest in Urological Topics During the Coronavirus Disease Pandemic.” J Urol. 2020. doi: 10.1097/JU.0000000000001187. [Epub ahead of print].

Rosen GH, Murray KS, Greene KL, Pruthi RS, Richstone L, and Mirza M. “Effect of COVID-19 on Urology Residency Training: A Nationwide Survey of Program Directors by the Society of Academic Urologists.” J Urol. 2020. doi:10.1097/JU.0000000000001155. [Epub ahead of print].

Oserowsky A, Allison D, Weinstein S, Nguyen V, and Murray KS. “Metastasis of Renal Cell Carcinoma to the Distal Ureteral Stump beyond Recommended Baseline Surveillance Duration.” Urol Case Rep. 2020; 32. doi: 10.1016/j.eucr.2020.101266.

Chouhan JD, Anwar T, Jones A, and Murray KS. “Burnout in the Urology Workforce: Voluntary Survey Results in the United States.” Urology Practice. 2020. doi: 10.1097/UPJ.0000000000156. [Epub ahead of print].

Kim K, Hu W, Audenet F, Almassi N, Hanrahan A, Murray K, Bagrodia A, Wong N, Dason S, Mohan V, Jebiwott S, Nagar K, Gao J, Penson A, Hughes C, Gordon B, Dong Y, Alvim R, Elzein A, Gao SP, Ostrovnaya I, Hsieh JJ, Sagi I, Pietzak EJ, Hakimi AA, Rosenberg JE, Iyer G, Scaltriti M, Al-Ahmadie H, Solit DB, and Coleman JA. “Modeling Biological and Genetic Diversity in Upper Tract Urothelial Carcinoma with Patient Derived Xenografts.” Nat Commun. 2020; 11(1975). doi: 10.1038/s41467-020-15885-7.

Mohapatra A, Strope SA, Liu N, Winer A, Benfante NE, Coleman JA, Vetter J, and Murray KS. “Importance of Long-Term Follow-Up after Endoscopic Management of Upper Tract Urothelial Carcinoma and Factors Leading to Surgical Management.” Int J Urol Neph. 2020; 52: 1465-9. doi: 10.1007/s11255-020-02439-5. 

Anwar T, Wakefield MR, and Murray KS. “The Role of Geography in the AUA Residency Match.” J Urol. 2020; 203(6): 1070-1. doi: 10.1097/JU.00000000000796.

Tracey AT*, Murray KS*, Coleman JA, and Kim K. “Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma.” Cancers. 2020; 12(2): 439. doi:10.3390/cancers12020439.

Rathbun JR, Thimmappa N, Weinstein SH, and Murray KS. “Ureteroinguinal Hernia with Obstructive Urolithiasis.” Int Braz J Urol. 2020; 46(5): 857-8. doi: 10.1590/S1677-5538.IBJU.2019.0415.

El-Arabi AM, Niu S, Chase B, Sherman G, Mirza M, Thrasher JB, and Nangia AJ. “Eighteen-Year Review of Resident Performance on the American Urologic Association In-Service Examination.” Urology. 2020; 137:33-7. doi: 10.1016/j.urology.2019.10.027.

Malm-Buatsi E, Anderson AGS, Gubbins E, PagePhilips E, Maizels M, and Washington KT. “A Qualitative Study of Prenatal Preferences for Postcircumcision Care Education.” J Pediatr Urol. 2020; 16(1):46.e1-46.e6. doi: 10.1016/j.jpurol.2019.10.010.

Rathbun JR and Malm-Buatsi E. “Weigert-Meyer Law Violation with Lower Pole Obstruction and Ectopia.” Surg Case Rep. 2020; 3(2): 2-4. doi: 10.31487/j.SCR.2020.02.06.

Yang W, Zhao L, Tang M, Jian Y, Zhu Z, Brady TJ, Xiao H, Bai Q, Wakefield MR, and Fang Y. “Disseminated Norcardia Infection in an Old Male patient with Nephrotic Syndrome.” Clin Lab. 2020: 1;66(1). doi: 10.7754/clin.Lab.2019.190638.

Russell CL, Hathaway D, Remy LM, Aholt D, Clark D, Miller C, Ashbaugh C, Wakefield M, Ye S, Staggs VS, Ellis RJ, and Goggin K. “Improving medication adherence and outcomes in adult kidney transplant patients using a personal system approach: SystemCHANGE results of the MAGIC randomized controlled clinical trial.” Am J Transplant. 2020; 20(1): 125-36. doi: 10.1111.ajt.15528.